Overexpression of EZH2 associates with a poor prognosis in chronic lymphocytic leukemia

被引：29
|
作者：
Rabello, Doralina do Amaral [1 ]
Lucena-Araujo, Antonio Roberto [2 ]
Rocha Alves-Silva, Juliana Carvalho [1 ]
Aboud Souza da Eira, Vinicius Burnett [1 ]
Cals de Vasconcellos, Maria Catarina [3 ]
de Oliveira, Fabio Morato [2 ]
Rego, Eduardo Magalhaes [2 ]
Saldanha-Araujo, Felipe [1 ]
Silva, Fabio Pittella [1 ]
机构：
[1] Univ Brasilia, Lab Mol Pathol Canc, BR-70910900 Brasilia, DF, Brazil
[2] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Internal Med, BR-14048900 Ribeirao Preto, SP, Brazil
[3] Hosp Base Dist Fed, Setor Hosp Sul, Area Especial, BR-70330150 Brasilia, DF, Brazil
来源：
BLOOD CELLS MOLECULES AND DISEASES | 2015年 / 54卷 / 01期
关键词：
Chronic lymphocytic leukemia; EZH2; Histone methyltransferase; Gene expression; Cytogenetic; ZAP-70; EXPRESSION; POLYCOMB; MECHANISMS; DIAGNOSIS; CELLS;
D O I：
10.1016/j.bcmd.2014.07.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EZH2, a histone methyltransferase, is overexpressed in several human tumors, but whether it exerts any impact in chronic lymphocytic leukemia (CLL) remains unknown. We used real time PCR to investigate the expression profile of EZH1 and EZH2 in 59 CLL patients, 10 samples of purified B-cells from healthy donors and 12 normal adult tissues. EZH2 was overexpressed in CLL patients and correlates with high white blood cell count, ZAP-70 expression and chromosomal abnormalities. EHZ1 expression does not correlate with CLL progression. EZH2 overexpression is related to a poor prognosis of CLL and could be a useful tool to assess its aggressiveness. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码：97 / 102
页数：6
相关论文
共 50 条
  • [21] MYC Rearrangement in Chronic Lymphocytic Leukemia, Is Not Often Associated with Poor Prognosis
    Li, Yan
    Hu, Shimin
    Wang, Sa
    Huh, Yang O.
    Li, Shaoying
    Medeiros, Jeffrey
    Tang, Guilin
    MODERN PATHOLOGY, 2016, 29 : 358A - 358A
  • [22] OVEREXPRESSION OF Ezh2 AS A TARGET IN TREATMENT OF GLIOMA
    Farassati, Faris
    Peng, Warner
    Lovick, Darren
    Shah, Kushal
    Ricke, Brandon
    NEURO-ONCOLOGY, 2016, 18 : 59 - 60
  • [23] EZH2, new diagnosis and prognosis marker in acute myeloid leukemia patients
    Mechaal, Amal
    Menif, Samia
    Abbes, Salem
    Safra, Ines
    ADVANCES IN MEDICAL SCIENCES, 2019, 64 (02): : 395 - 401
  • [24] External Stimuli Modulate EZH2 Expression in Chronic Lymphocytic Leukemia. Rationale and Evidence for Synergistic Anti-Tumor Effects of B Cell Signaling and EZH2 Inhibitors
    Chartomatsidou, Elisavet
    Ntoufa, Stavroula
    Kotta, Konstantia
    Akritidou, Marianna
    Trangas, Theoni
    Stavroyianni, Niki
    Anagnostopoulos, Achilles
    Rosenquist, Richard
    Ghia, Paolo
    Papakonstantinou, Nikos
    Stamatopoulos, Kostas
    BLOOD, 2017, 130
  • [25] Overexpression of EZH2 in mammary gland tumorigenesis
    Li, Xin
    Gonzalez, Maria
    Toy, Kathy
    Merajver, Sofia
    Kleer, Celina
    CANCER RESEARCH, 2009, 69
  • [26] DECIPHERING AND TARGETING EZH2 OVEREXPRESSION IN MEDULLOBLASTOMA
    Danis, Etienne
    Pierce, Angela
    Balakrishan, Ilango
    Wang, Dong
    Venkataraman, Sujatha
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2018, 20 : 138 - 138
  • [27] Prognosis in Chronic Lymphocytic Leukemia
    Yavorkovsky, Leonid L.
    JAMA ONCOLOGY, 2015, 1 (07) : 988 - 988
  • [28] Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) is associated with cancer metastasis and poor prognosis in breast cancer
    Guo, Yawen
    Maimaiti, Yusufu
    Yu, Pan
    Liu, Zeming
    Chen, Chen
    Zhang, Yunke
    Yin, Xingjie
    Wang, Shan
    Xiu, Nie
    Bangxing, Huang
    Liu, Chunping
    Huang, Tao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 2672 - 2683
  • [29] Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma
    Kyasa, MJ
    Parrish, RS
    Schichman, SA
    Zent, CS
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 74 (01) : 1 - 8
  • [30] RISK STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA ACCORDING TO THE NUMBER OF FACTORS OF POOR PROGNOSIS
    Alpoim, M.
    Fernandes, C.
    Garrido, T.
    Carneiro, A.
    Aguiar Andrade, J.
    Guimaraes, J. E.
    HAEMATOLOGICA, 2014, 99 : 589 - 589
12345